Rankings
▼
Calendar
HRTX Q1 2025 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$162M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$39M
+12.2% YoY
Gross Profit
$30M
78.3% margin
Operating Income
$3M
8.1% margin
Net Income
$3M
6.8% margin
EPS (Diluted)
$0.02
QoQ Revenue Growth
-4.6%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$236M
Total Liabilities
$264M
Stockholders' Equity
-$28M
Cash & Equivalents
$19M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$39M
$35M
+12.2%
Gross Profit
$30M
$26M
+16.1%
Operating Income
$3M
-$5M
+165.7%
Net Income
$3M
-$3M
+183.4%
Revenue Segments
C I N V A N T I
$26M
70%
Z Y N R E L E F
$8M
22%
S U S T O L
$3M
8%
← FY 2025
All Quarters
Q2 2025 →